Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 5, 1996, Pages 409-413

  Devine, Dana V ^a   Bishop, Paul D ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ZYMOGENETICS INC   (United States)

Author keywords

clot stabilization; factor XIII; fibrin; glycoprotein IIb IIIa; platelet activation

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 13; FIBRIN; FIBRINOGEN RECEPTOR;

BLOOD CLOT; BLOOD CLOTTING; CELL ADHESION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION;

EID: 0030461178     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999039     Document Type: Review

References (42)

1. Lorand L, J-M Jeong, JT Radek, J Wilson: Human plasma factor XIII: Subunit interactions and activation of zymogen. Method Enzymol 222:22-35, 1993.
2. Henriksson P, S Becker, G Lynch, J McDonagh: Identification of intracellular factor XIII in human rnonocytes and macrophages. J Clin Invest 76:528-534, 1985.
3. Poon M-C, JA Russell, S Low, GD Sinclair, AR Jones, W Blahey, BA Reuther, DI Hoar: Hemopoietic origin of factor XIII A subunits in platelets, monocytes and plasma. Evidence from hone marrow transplantation studies. J Clin Invest 84:787-792, 1984.
4. Buluk K, T Januszko, J Olbromski: Conversion of fibrin to desmofibrin. Nature 191:1093-1094, 1961.
5. Lorand L, AJ Gray, K Brown, RB Credo, CG Curtis, RA Domanik, P Stenberg: Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen. Biochem Biophys Res Commun 56:914-922, 1974.
6. Francis CW, VJ Marder: Degradation of cross-linked fibrin by human leukocyte proteases. J Lab Clin Med 107:342-352, 1986.
7. Sixma JJ, A van den Berg, M Schiphorst, HJ Geuze, J McDonagh: Immunocytochemical localization of albumin and factor XIII in thin cryosections of human blood platelets. Thromb Haemost 51: 388-391, 1984.
8. Kaplan KL, C Smith: Secretion of platelet factor XIII. Blood 82(suppl 1):157a, 1993.
9. Muszbek L, J Polgar, Z Boda: Platelet factor XIII becomes active without the release of activation peptide during platelet activation. Thromb Haemost 69:282-285, 1993.
10. Lynch GW, SL Pfueller: Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease. Thromb Haemost 60:372-377, 1988.
11. Ando Y, S Imamura, Y Yamagata, A Kitahara, H Saji, T Murachi, R Kannagi: Platelet factor XIII is activated by calpain. Biochem Biophys Res Commun 144:484-490, 1987.
12. Francis CW, VJ Marder: Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII. J Clin Invest 80:1459-1465, 1987.
13. Joist JH, S Niewiarowski: Retention of platelet fibrin stabilizing factor during the platelet release reaction and clot retraction. Thromb Diathes Haemorrh 29:679-683, 1973.
14. Greenberg CS, MA Shuman: Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets. J Biol Chem 259:14721-14727, 1984.
15. Cox AD, DV Devine: Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa. Blood 83: 1006-1016, 1994.
16. Holme PA, F Brosstad, NO Solum: The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation. Thromb Haemost 70:681-686, 1993.
17. Bishop PD, DC Teller, RA Smith, GW Lasser, T Gilbert, RL Seale: Expression, purification and characterization of human factor XIII in Saccharomyces cerevisiae. Biochemistry 29:1861-1869, 1990.
18. Devine DV, G Andestad, D Nugent, CJ Carter: Platelet-associated factor XIII as a marker of platelet activation in patients with severe peripheral vascular disease. Arterioscler Thromb 13:857-863, 1993.
19. Devine DV: Novel markers of platelet activation. Trans Med Rev 4:115-120, 1990.
20. McManama G, JN Lindon, M Kloczewiak, MA Smith, JA Ware, J Hawiger, EW Merrill, EW Salzman: Platelet aggregation by ribrinogen polymers crosslinked across the E domain. Blood 68: 363-371, 1986.
21. Rubens F, J Brash, J Weitz, R Kinlough-Rathbone: Interactions of thermally denatured fibrinogen on polyethylene with plasma proteins and platelets. J Biomed Material Res 26:1651-1663, 1992.
22. Farrell DH, P Thiagarajan: Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 269:226-231, 1994.
23. Rubens FD, DW Perry, MWC Hatton, PD Bishop, MA Packham, RL Kinlough-Rathbone: Platelet accumulation on fibrin-coated polyethylene: Role of platelet activation and factor XIII. Thromb Haemost 73:850-856, 1995.
24. Jungi TW, MO Spycher, UE Nydegger, S Barandun: Platelet-leukocyte interactions: Selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leukocytes and related cell lines. Blood 67:629-636, 1986.
25. Reed GL, GR Matseuda, E Haber: Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha-2-antiplasmin to fibrin. Thromb Haemost 68:315-320, 1992.
26. Shebuski RJ, GR Sitko, DA Claremon, JJ Baldwin, DC Remy, AM Stern: Inhibition of factor XIIIa in a canine model of coronary thrombosis: Effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator. Blood 75:1455-1459, 1990.
27. Leidy EM, AM Stern, PA Friedman, LR Bush: Enhanced thrombolysis by a factor XIIIa inhibitor in a rabbit model of femoral artery thrombosis. Thromb Res 59:15-26, 1990.
28. Bale MD, DF Mosher: Thrombospondin is a substrate for factor XIIIa. Biochemistry 25:5667-5673, 1986.
29. Hada M, M Kaminski, P Bockenstedt, J McDonagh: Covalent crosslinking of von Willebrand factor to fibrin. Blood 68:95-101, 1986.
30. Mosher D: Crosslink of cold-insoluble globulin by fibrin-stabilizing factor. J Biol Chem 250:6614-6621, 1975.
31. Wang DL, AE Annamalai, S Ghosh, AN Gewirtz, RW Colman: Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin. Thromb Res 57:38-57, 1990.
32. Berth W, V Chang, P Bishop, PC Harpel: Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase. J Biol Chem 266:18149-18153, 1991.
33. Jensen PH, L Lorand, P Ebbesen, J Gliemann: Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Eur J Biochem 214:141-145, 1993.
34. Cohen A, T Glaser, A Veis, J Bruner-Lorand: Ca2+-dependent cross-linking processes in human platelets. Biochim Biophys Acta 676:137-147, 1981.
35. Kreager JA, DV Devine, CS Greenberg: Cytofluorometric identification of plasmin-sensitive factor XIII binding to platelets. Thromb Haemost 60:88-93, 1988.
36. Hansen MS: Fibronectin and coagulation factor XIII increase blood platelet adhesion to fibrin. Thromb Res 34:551-556, 1984.
37. Usui T, J Takagi, Y Saito: Propolypeptide of von Willebrand factor serves as a substrate for factor XIIIa and is cross-linked to laminin. J Biol Chem 268:12311-12316, 1993.
38. Barry ELR, DF Mosher: Factor XIIIa-mediated crosslinking of fibronectin in fibroblast cell layers. J Biol Chem 264:4179-4185, 1989.
39. Sakata Y, N Aoki: Crosslinking of alpha-2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest 65:290-297, 1980.
40. Sane DC, TL Moser, AMM Pippen, CJ Parker, KE Achyuthan, CS Greenberg: Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun 157:115-120, 1988.
41. Mosher DF, PE Shad, HK Kleinman: Crosslinking of fibronectin to collagen by blood coagulation factor XIIIa. J Clin Invest 64:781-787, 1989.
42. Bockenstedt P, J McDonagh, RI Handin: Binding and covalent crosslinking of purified von Willebrand factor to native monomeric collagen. J Clin Invest 78:551-556, 1986.